These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22406595)

  • 1. Translational research. New findings and potential future applications in pancreatic adenocarcinoma.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2012 Mar; 13(2):177-9. PubMed ID: 22406595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: updates on translational research and future applications.
    Sarris EG; Syrigos KN; Saif MW
    JOP; 2013 Mar; 14(2):145-8. PubMed ID: 23474558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers and pharmacogenetics in pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Xu X; Strimpakos AS; Saif MW
    JOP; 2011 Jul; 12(4):325-9. PubMed ID: 21737888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational research in pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2010 Mar; 11(2):124-7. PubMed ID: 20208318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum tumor markers at exocrine adenocarcinoma of pancreas].
    Holubec L; Finek J; Topolcan O; Svobodová S
    Cas Lek Cesk; 2005; 144(2):86-8; discussion 89. PubMed ID: 15807292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Richter J; Saif MW
    JOP; 2010 Mar; 11(2):139-43. PubMed ID: 20208322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of pancreatic cancer.
    Eguia V; Gonda TA; Saif MW
    JOP; 2012 Mar; 13(2):131-4. PubMed ID: 22406583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New frontiers in pancreatic cancer research.
    Khan GN; di Magliano MP; Simeone DM
    Surg Oncol Clin N Am; 2010 Apr; 19(2):431-51. PubMed ID: 20159524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel targets for pancreatic cancer therapy.
    Philip PA
    Surg Oncol Clin N Am; 2010 Apr; 19(2):419-29. PubMed ID: 20159523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.
    Jazieh KA; Foote MB; Diaz LA
    Semin Radiat Oncol; 2014 Apr; 24(2):67-76. PubMed ID: 24635863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational research in pancreatic adenocarcinoma.
    Kaur G; Saif MW
    JOP; 2014 Mar; 15(2):121-3. PubMed ID: 24618433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
    Mazur PK; Siveke JT
    Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble iC3b as an early marker for pancreatic adenocarcinoma is superior to CA19.9 and radiology.
    Märten A; Büchler MW; Werft W; Wente MN; Kirschfink M; Schmidt J
    J Immunother; 2010; 33(2):219-24. PubMed ID: 20139773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced pancreatic adenocarcinoma: update and progress.
    Ng J; Zhang C; Gidea-Addeo D; Saif MW
    JOP; 2012 Mar; 13(2):155-8. PubMed ID: 22406589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limitations in improving detection of pancreatic adenocarcinoma.
    Mendieta Zerón H; García Flores JR; Romero Prieto ML
    Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant strategies for resectable pancreatic cancer: have we made progress?
    Russo S; Jain AK; Saif MW
    JOP; 2012 Mar; 13(2):139-42. PubMed ID: 22406585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma of the pancreas--past, present and future.
    Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
    Hepatogastroenterology; 2005; 52(64):1281-92. PubMed ID: 16001679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1: a marker for pancreatic cancer diagnosis.
    Tanase CP
    Expert Rev Mol Diagn; 2008 Jul; 8(4):395-404. PubMed ID: 18598222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of borderline resectable pancreatic adenocarcinoma.
    Jia Y; Wang TJ; Allendorf J; Saif MW
    JOP; 2012 Mar; 13(2):147-50. PubMed ID: 22406587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
    Singh P; Srinivasan R; Wig JD
    Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.